Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
US military marks 11th successive night of attacks on Iran
Under soaring pressure, India's education minister promises reforms and debate
Rubio says US still willing to negotiate over Iran crisis
Trump says US airlines can now fly to Lebanon for first time since 1985
Bahrain, Kuwait, Jordan face renewed Iranian attacks after US hits Iran's south
